• 1
    Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239257.
  • 2
    Shen W, Kamendulis LM, Ray SD, Corcoran GB. Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: Correlation of nuclear Ca2+ accumulation and early DNA fragmentation with cell death. Toxicol Appl Pharmacol 1991; 111: 242254.
  • 3
    Benedetti A, Brunelli E, Risicato R, Cilluffo T, Jesequel AM, Orlandi F. Subcellular changes and apoptosis induced by ethanol in rat liver. J Hepa-to 1988; 6: 137143.
  • 4
    Ledda-Columbano GM, Coni P, Curto M, Giacomini L, Faa G, Oliverio S, Piacentini M, et al. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver and after a single dose of thioacetamide. Am J Pathol 1991; 139: 10991109.
  • 5
    Searle J, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 1987; 171: 3751.
  • 6
    Bursch W, Buesterberg B, Schulte-Hermann R. Growth. Regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol 1986; 95: 221227.
  • 7
    Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806809.
  • 8
    Terrell TG, Woking PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol 1993; 34: 4367.
  • 9
    Oberhammer F, Bursch W, Tiefenbacher R, Froschl G, Pavelka M, Purchio T, Schulte-Hermann R. Apoptosis is induced by transforming growth factor-β1 within 5 hr in regressing liver without significant fragmentation of the DNA. Hepatology 1993; 18: 12381246.
  • 10
    Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci U S A 1992; 89: 54085412.
  • 11
    Lin J-K, Chou C-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factorβ1 Cancer Res 1992; 52: 385388.
  • 12
    Fukuda K, Kojiro M, Chiu J-F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: A possible association with tissue transglutaminase expression. Hepatology 1993; 18: 945953.
  • 13
    Cain K, Inayat-Hussain SH, Couet C, Cohen GM. A cleavage-site-directed inhibitor of interleukin-β-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochem J 1996; 314: 2732.
  • 14
    Chinnaiyan AM, Dixit VM. The cell death machine. Curr Biol 1996; 6: 555562.
  • 15
    Takahashi A, Earnshaw WC. ICE-related proteases in apoptosis. Curr Opin Gen Dev 1996; 5: 5055.
  • 16
    Kumar S, Tomooka Y, Noda M. Identification of a set of genes with develop-mentally down regulated expression in the mouse brain. Biochem Biophys Res Commun 1992; 185: 11551161.
  • 17
    Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1 an Ice/ced-3-related gene encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739750.
  • 18
    Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin- l-β-converting enzyme. J Biol Chem 1994; 269: 343352.
  • 19
    Faucheu C, Dm A, Chan AWE, Blanchet A-M, Miossec C, Herve F, Collard-Dutilleul V, et al. A novel human protease similar to the interleukin-1 β-converting enzyme induces apoptosis in transfected cells. EMBO J 1995; 14: 19141922.
  • 20
    Fernandes-Alnemri T, Litwack G, Alnemri ES. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 1995; 55: 27372742.
  • 21
    Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Frits L, Toma-selli KJ, Wand L, et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 1995; 55: 60456052.
  • 22
    Thornberry NA, Molineux SM. Interleukin-1 β converting enzyme: A novel cysteine protease required for IL-1 β production and implicated in programmed cell death. Prot Sci 1995; 4: 312.
  • 23
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, et al. Identification and inhibition of the ICE/Ced-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 3743.
  • 24
    Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kos-tura MJ, Miller DK, et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992; 356: 768774.
  • 25
    Dolle RE, Hoyer D, Prasad VC, Schmidt SJ, Helaszek CT, Miller RE, Ator MA. P1 aspartate-based peptide α-(2,6-dichlorobenzoyl)oxy)methylketones as potent time-dependent inhibitors of interleukin-1 β-converting enzyme. J Med Chem 1994; 37: 563564.
  • 26
    Miller BE, Krasney PA, Gauvin DM, Holbrook KB, Koonz DJ, Abruzzese RV, Miller RE, et al. Inhibition of mature IL-1 β production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 βconverting enzyme. J Immunol 1995; 154: 13311338.
  • 27
    Chow SC, Weis M, Kass GEN, Holstrom TH, Eriksson JE, Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in lymphocytes. FEES Lett 1995; 364: 134138.
  • 28
    Pronk GJ, Ramer K, Amiri P, Williams LT. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996; 271: 808810.
  • 29
    Zhu H, Fearnhead HO, Cohen GM. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.l cells. FEBS Lett 1995; 374: 303308.
  • 30
    Fearnhead HO, Dinsdale D, Cohen GM. An interleukin 1 β-converting enzyme is common mediator of apoptosis in thymocytes. FEBS Lett 1995; 375: 283288.
  • 31
    Jacobson MD, Weil M, Raff MC. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 1996; 133: 10411051.
  • 32
    Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1995; 315: 2124.
  • 33
    MacFarlane M, Cain K, Sun X-M, Alnemri ES, Cohen GM. Cleavage/activation of at least four ICE-like proteases accompanies the execution of apoptosis in human monocytic tumour cells. J Cell Biol 1997; 137: 111.
  • 34
    Cain K, Inayat-Hussain SH, Couet C, Qin H-M, Oberhammer FA. A novel method for detecting apoptosis shows that hepatoctyes undergo a time dependent increase in DNA cleavage and chromatin condensation which is augmented after TGF-β1 treatment. Cytometry 1996; 23: 312321.
  • 35
    Thornberry NA. Interleukin-1 β converting enzyme. Methods Enzymol 1994; 244: 615631.
  • 36
    Thornberry NA, Peterson EP, Zhao JT, Howard AD, Griffin PR, Chapman KT. Inactivation of interleukin-1 β converting enzyme by peptide (acyloxy) methylketones. Biochem 1994; 33: 39343940.
  • 37
    Morrison JF. The slow binding and slow tight-binding inhibition of enzyme catalysed reactions. Trends Biochem Sci 1982; 7: 102105.
  • 38
    Armstrong RC, Fernandes-Alnemri TA, Xiang J, Gaur S, Krebs JF, Hoang K, Bait X, et al. Fas-induced activation of the cell death-related protease CPP32 is inhibited by BcL-2 and by ICE family protease inhibitors. J Biol Chem 1996; 271: 1685016855.
  • 39
    Faa G, Ledda-Columbano GM, Ambu R, Congiu T, Coni P, Riva A, Colum-bano A. An electron microscopic study of apoptosis induced by cyclohexi-mide in rat liver. Liver 1994; 14: 270278.
  • 40
    Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrine Rev 1993; 14: 133151.
  • 41
    Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula MS, Wang L, Bullrich F, Fritz LC, et al. In vitro activation of CPP32 and Mch3 α by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A 1996; 93: 74647469.
  • 42
    Wang Z-Q, Auer B, Sting L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995; 9: 509520.
  • 43
    Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996; 184: 20672072.
  • 44
    Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 7881.
  • 45
    Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996; 380: 723726.
  • 46
    Kwo P, Patel T, Bronk SF, Gores GJ. Nuclear serine protease activity contributes to bile acid-induced apoptosis. Am J Physiol 1995; 268: 613621.
  • 47
    Gant TW, Silverman JE, Thorgeirsson SS. Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a drafts-acting transcriptional represser. Nucleic Acids Res 1992; 20: 28412846.
  • 48
    Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel Mortl/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85: 803815.
  • 49
    Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, et al. FLICE, a novel FADD-homologous ICE/CED-1-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signalling complex. Cell 1996; 85: 817827.
  • 50
    Niehrs C. Mad connection to the nucleus. Nature 1996; 381: 561562.